Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2543976540;76541;76542 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
N2AB2379871617;71618;71619 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
N2A2287168836;68837;68838 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
N2B1637449345;49346;49347 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
Novex-11649949720;49721;49722 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
Novex-21656649921;49922;49923 chr2:178569817;178569816;178569815chr2:179434544;179434543;179434542
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-73
  • Domain position: 35
  • Structural Position: 37
  • Q(SASA): 0.101
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/R None None 0.999 N 0.882 0.386 0.517819333224 gnomAD-4.0.0 1.59198E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85923E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.3385 likely_benign 0.2621 benign -0.612 Destabilizing 0.619 D 0.385 neutral N 0.515318279 None None N
G/C 0.5877 likely_pathogenic 0.5353 ambiguous -0.939 Destabilizing 1.0 D 0.883 deleterious None None None None N
G/D 0.8874 likely_pathogenic 0.879 pathogenic -1.224 Destabilizing 0.998 D 0.8 deleterious None None None None N
G/E 0.8992 likely_pathogenic 0.8987 pathogenic -1.174 Destabilizing 0.998 D 0.857 deleterious N 0.472104983 None None N
G/F 0.9547 likely_pathogenic 0.9435 pathogenic -0.674 Destabilizing 1.0 D 0.885 deleterious None None None None N
G/H 0.8758 likely_pathogenic 0.8627 pathogenic -1.355 Destabilizing 1.0 D 0.867 deleterious None None None None N
G/I 0.9518 likely_pathogenic 0.9384 pathogenic 0.084 Stabilizing 0.999 D 0.894 deleterious None None None None N
G/K 0.924 likely_pathogenic 0.9357 pathogenic -0.893 Destabilizing 0.998 D 0.862 deleterious None None None None N
G/L 0.9337 likely_pathogenic 0.9167 pathogenic 0.084 Stabilizing 0.998 D 0.863 deleterious None None None None N
G/M 0.928 likely_pathogenic 0.9133 pathogenic -0.18 Destabilizing 1.0 D 0.879 deleterious None None None None N
G/N 0.7718 likely_pathogenic 0.7752 pathogenic -0.814 Destabilizing 0.998 D 0.686 prob.neutral None None None None N
G/P 0.9989 likely_pathogenic 0.9984 pathogenic -0.105 Destabilizing 0.999 D 0.866 deleterious None None None None N
G/Q 0.8508 likely_pathogenic 0.8573 pathogenic -0.838 Destabilizing 0.999 D 0.885 deleterious None None None None N
G/R 0.8489 likely_pathogenic 0.8638 pathogenic -0.869 Destabilizing 0.999 D 0.882 deleterious N 0.475245309 None None N
G/S 0.242 likely_benign 0.2162 benign -1.177 Destabilizing 0.935 D 0.388 neutral None None None None N
G/T 0.6957 likely_pathogenic 0.6838 pathogenic -1.028 Destabilizing 0.996 D 0.799 deleterious None None None None N
G/V 0.8901 likely_pathogenic 0.8669 pathogenic -0.105 Destabilizing 0.998 D 0.863 deleterious N 0.500630945 None None N
G/W 0.9234 likely_pathogenic 0.9044 pathogenic -1.201 Destabilizing 1.0 D 0.843 deleterious None None None None N
G/Y 0.8711 likely_pathogenic 0.8549 pathogenic -0.675 Destabilizing 1.0 D 0.887 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.